Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)
Clinical trial NCT04635839 · COMPLETED
Trial details
- NCT number
- NCT04635839
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-03-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.